The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems
Open accessThe DOI matches its Crossref record; 418 of the 418 references it cites were found in a registry or an index.
Abstract
Opioid abuse has increased in the last decade, primarily as a result of increased access to prescription opioids. Physicians are also increasingly administering opioid analgesics for noncancer chronic pain. Thus, knowledge of the long-term consequences of opioid use/abuse has important implications for fully evaluating the clinical usefulness of opioid medications. Many studies have examined the effect of opioids on the endocrine system; however, a systematic review of the endocrine actions of opioids in both humans and animals has, to our knowledge, not been published since 1984. Thus, we reviewed the literature on the effect of opioids on the endocrine system. We included both acute and chronic effects of opioids, with the majority of the studies done on the acute effects although chronic effects are more physiologically relevant. In humans and laboratory animals, opioids generally increase GH and prolactin and decrease LH, testosterone, estradiol, and oxytocin. In humans, opioids increase TSH, whereas in rodents, TSH is decreased. In both rodents and humans, the reports of effects of opioids on arginine vasopressin and ACTH are conflicting. Opioids act preferentially at different receptor sites leading to stimulatory or inhibitory effects on hormone release. Increasing opioid abuse primarily leads to hypogonadism but may also affect the secretion of other pituitary hormones. The potential consequences of hypogonadism include decreased libido and erectile dysfunction in men, oligomenorrhea or amenorrhea in women, and bone loss or infertility in both sexes. Opioids may increase or decrease food intake, depending on the type of opioid and the duration of action. Additionally, opioids may act through the sympathetic nervous system to cause hyperglycemia and impaired insulin secretion. In this review, recent information regarding endocrine disorders among opioid abusers is presented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, it is important to keep in mind that some medications (eg, high doses of heparins, phenobarbital, opioids, and etomidate) used in the ICU may adversely impact endocrine function or may alter the accuracy of laboratory testing (152, 153).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [153]
In the citing paper
“Opioids inhibit pulsatile GnRH secretion from the hypothalamus and the secretion of gonadotropins (mainly LH and to a lesser extent FSH) from the pituitary gland and of sex steroids from the gonads (61)(62)(63)(64).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [63]
In the citing paper
“In animals, depending on the dose, timing and duration, opioids have been shown to variably stimulate or inhibit the CRH/ACTH axis, whereas in humans they predominantly inhibit it [61].”
In the citing paper
“The physiological relationship between the opioid and OT systems has been firmly established (20).”
From Oxytocin under opioid antagonism leads to supralinear enhancement of social attention (2017) · cites this paper as [20]
Citations
Cites
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e560352009-001 · Cited by 6,921
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
How does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505
A potent and selective endogenous agonist for the µ-opiate receptor
Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,311
Endogenous Opioids: Biology and Function
Akil, H., Watson, S. J., Young, E., Lewis, M. E., Khachaturian, H., & Walker, J. M. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001255 · Cited by 1,224
Common precursor to corticotropins and endorphins
Mains, R. E., Eipper, B. A., & Ling, N. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.7.3014 · Cited by 1,105 · cited 1×
“Subsequently, CRH binds to its receptor in the anterior pituitary that leads to the synthesis of POMC, a large precursor molecule that is cleaved into several smaller functional peptides, such as ACTH and -endorphin (67).”
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079 · cited 1×
“been established unequivocally (288), some studies indi-”
Opioid Therapy for Chronic Pain
Ballantyne, J. C., & Mao, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra025411 · Cited by 959 · cited 2×
“-Endorphin Leu-enkephalin 0 Met-enkephalin 0 Dynorphin A (1-17) 0 Endomorphin-1 0 0 Endomorphin-2 0 0 Morphine 0 Heroin 0 Fentanyl 0 0 Sufentanil 0 0 Methadone 0 0 DALA (FK 33-824) 0 DAMME 0 U50,488H 0 0 Nalorphine 0 Naloxone Naltrexone CTOP 0 0 Buprenorphine / (?) Pentazocin 0”
Major increases in opioid analgesic abuse in the United States: Concerns and strategies
Compton, W. M., & Volkow, N. D. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.009 · Cited by 830 · cited 3×
“-Endorphin Leu-enkephalin 0 Met-enkephalin 0 Dynorphin A (1-17) 0 Endomorphin-1 0 0 Endomorphin-2 0 0 Morphine 0 Heroin 0 Fentanyl 0 0 Sufentanil 0 0 Methadone 0 0 DALA (FK 33-824) 0 DAMME 0 U50,488H 0 0 Nalorphine 0 Naloxone Naltrexone CTOP 0 0 Buprenorphine / (?) Pentazocin 0”
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791 · cited 1×
“In males, chronic hypogonadism, either spontaneous or induced by GnRH agonists, is associated with increased insulin resistance and risk for diabetes mellitus, but not frank hyperglycemia (398), and testosterone replacement may improve insulin resistance (399).”
Opioid and Nonopioid Mechanisms of Stress Analgesia
Lewis, J. W., Cannon, J. T., & Liebeskind, J. C. (1980) · Science · doi:10.1126/science.7367889 · Cited by 738
Drug dependence: stress and dysregulation of brain reward pathways
Kreek, M. J., & Koob, G. F. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00064-7 · Cited by 696
Steiner, D. F. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80033-1 · Cited by 650
Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord
Arvidsson, U., Riedl, M., Chakrabarti, S., Lee, J., Nakano, A., Dado, R., Loh, H., Law, P., Wessendorf, M., & Elde, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03328.1995 · Cited by 637
Bruni, J. F., Van Vugt, D., Marshall, S., & Meites, J. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90528-8 · Cited by 578 · cited 1×
“trast to earlier reports that naloxone had no effect on basal (141) or cold-stimulated TSH secretion (142), more recent reports have shown an attenuating effect of opioid antagonists.”
Opioid-induced Hyperalgesia in Humans: Molecular Mechanisms and Clinical Considerations
Chu, L. F., Angst, M. S., & Clark, D. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816b2f43 · Cited by 575 · cited 1×
“However, in patients, chronic administration of opioid analgesics, such as morphine, at least under some conditions, produces a state of higher pain sensitivity or hyperalgesia (47).”
Cardiovascular Effects of Endogenous Opiate Systems
Holaday, J. W. (1983) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.23.040183.002545 · Cited by 571
Pain and Stress in a Systems Perspective: Reciprocal Neural, Endocrine, and Immune Interactions
Chapman, C. R., Tuckett, R. P., & Song, C. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.006 · Cited by 541 · cited 1×
“These studies will require adequate controls for severity and perhaps different types of pain because pain itself has multiple effects on the endocrine system (403).”
Stimulation of food intake by muscimol and beta endorphin
Grandison, L., & Guidotti, A. (1977) · Neuropharmacology · doi:10.1016/0028-3908(77)90019-3 · Cited by 528
Neural peptides and neuronal communication.
Costa, E., & Trabucchi, M. (1980) · PubMed · Cited by 522
Vandesande, F., & Dierickx, K. (1975) · Cell and Tissue Research · doi:10.1007/bf00218970 · Cited by 496
Endocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
Role of Corticotropin-Releasing Factor in Drug Addiction: Potential for Pharmacological Intervention
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 476
Role of endogenous opioid system in the regulation of the stress response
Drolet, G., Dumont, É. C., Gosselin, I., Kinkead, R., Laforest, S., & Trottier, J.-F. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00161-0 · Cited by 421 · cited 1×
“Indeed, a growing body of evidence suggests that opioids regulate mechanisms activated during the stress response (58, 60).”
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000
Caudill-Slosberg, M. A., Schwartz, L. M., & Woloshin, S. (2004) · Pain · doi:10.1016/j.pain.2004.03.006 · Cited by 374
75 years of opioid research: the exciting but vain quest for the Holy Grail
Corbett, A. D., Henderson, G., McKnight, A. T., & Paterson, S. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706435 · Cited by 358 · cited 2×
“Endogenous morphine has been found in low concentrations in the brain (50).”
Drug Abuse, Dependence, and Addiction in Chronic Pain Patients
Fishbain, D. A., Rosomoff, H. L., & Rosomoff, R. S. (1992) · The Clinical Journal of Pain · doi:10.1097/00002508-199206000-00003 · Cited by 357 · cited 3×
“-Endorphin Leu-enkephalin 0 Met-enkephalin 0 Dynorphin A (1-17) 0 Endomorphin-1 0 0 Endomorphin-2 0 0 Morphine 0 Heroin 0 Fentanyl 0 0 Sufentanil 0 0 Methadone 0 0 DALA (FK 33-824) 0 DAMME 0 U50,488H 0 0 Nalorphine 0 Naloxone Naltrexone CTOP 0 0 Buprenorphine / (?) Pentazocin 0”
Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort
Gfroerer, J. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00307-1 · Cited by 355 · cited 2×
“-Endorphin Leu-enkephalin 0 Met-enkephalin 0 Dynorphin A (1-17) 0 Endomorphin-1 0 0 Endomorphin-2 0 0 Morphine 0 Heroin 0 Fentanyl 0 0 Sufentanil 0 0 Methadone 0 0 DALA (FK 33-824) 0 DAMME 0 U50,488H 0 0 Nalorphine 0 Naloxone Naltrexone CTOP 0 0 Buprenorphine / (?) Pentazocin 0”
Bupropion: pharmacology and therapeutic applications
Foley, K. F., DeSanty, K. P., & Kast, R. E. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.9.1249 · Cited by 352 · cited 1×
“smoking cessation (389) that is a putative stimulator of the”
The Role of Corticotropin-Releasing Factor in Drug Addiction
Sarnyai, Z., Shaham, Y., & Heinrichs, S. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01492-3 · Cited by 351 · cited 1×
“Indeed, a growing body of evidence suggests that opioids regulate mechanisms activated during the stress response (58, 60).”
Molecular biology of the opioid receptors: structures, functions and distributions
Minami, M., & Satoh, M. (1995) · Neuroscience Research · doi:10.1016/0168-0102(95)00933-k · Cited by 346
Rational Design of a Combination Medication for the Treatment of Obesity
Greenway, F. L., Whitehouse, M. J., Guttadauria, M., Anderson, J. W., Atkinson, R. L., Fujioka, K., Gadde, K. M., Gupta, A. K., O'Neil, P., Schumacher, D., et al. (2009) · Obesity · doi:10.1038/oby.2008.461 · Cited by 345 · cited 1×
“animal model and a small clinical study (390).”
Immunohistochemical localization of ?-opioid receptors in the central nervous system of the rat
Ding, Y.-Q., Kaneko, T., Nomura, S., & Mizuno, N. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960408)367:3<375::aid-cne5>3.0.co;2-2 · Cited by 336
Van Uum, S. H. M., Sauvé, B., Fraser, L. A., Morley-Forster, P., Paul, T. L., & Koren, G. (2008) · Stress · doi:10.1080/10253890801887388 · Cited by 332 · cited 1×
“This lack of differences across the circadian rhythm may explain why the overall long-term cortisol exposure (as measured by hair cortisol levels) was elevated in opioid-treated chronic pain patients compared with control subjects (191).”
Lightman, S. L., & Young, W. S. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016858 · Cited by 324 · cited 1×
“Opioid-containing neurons have been shown to innervate the median eminence and paraventricular nucleus of the hypothalamus, thereby regulating inputs to ACTH-controlling neurons in the anterior pituitary (61, 62).”
Prevalence and characteristics of opioid use in the US adult population
Kelly, J. P., Cook, S. F., Kaufman, D. W., Anderson, T., Rosenberg, L., & Mitchell, A. A. (2008) · Pain · doi:10.1016/j.pain.2008.01.027 · Cited by 309 · cited 4×
“-Endorphin Leu-enkephalin 0 Met-enkephalin 0 Dynorphin A (1-17) 0 Endomorphin-1 0 0 Endomorphin-2 0 0 Morphine 0 Heroin 0 Fentanyl 0 0 Sufentanil 0 0 Methadone 0 0 DALA (FK 33-824) 0 DAMME 0 U50,488H 0 0 Nalorphine 0 Naloxone Naltrexone CTOP 0 0 Buprenorphine / (?) Pentazocin 0”
InfluentialEndocrine Effects of Naloxone-Induced Opiate Receptor Blockade *
MORLEY, J. E., BARANETSKY, N. G., WINGERT, T. D., CARLSON, H. E., HERSHMAN, J. M., MELMED, S., LEVIN, S. R., JAMISON, K. R., WEITZMAN, R., CHANG, R. J., et al. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-251 · Cited by 300 · cited 1×
“Two studies which found that naloxone did not affect PRL levels studied both men and women together and used small numbers of subjects (127, 128).”
Goeders, N. E. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.785 · Cited by 286 · cited 1×
“The inhibitory action of cortisol/CS, however, can be overcome by further release of CRH under severe or chronic stress situations (65, 68).”
Frenk, H. (1983) · Brain Research Reviews · doi:10.1016/0165-0173(83)90039-5 · Cited by 283
The endocrinology of the opiates and opioid peptides
Morley, J. E. (1981) · Metabolism · doi:10.1016/0026-0495(81)90172-4 · Cited by 283 · cited 1×
“trast to earlier reports that naloxone had no effect on basal (141) or cold-stimulated TSH secretion (142), more recent reports have shown an attenuating effect of opioid antagonists.”
Testosterone, body composition and aging.
Vermeulen, A., Goemaere, S., & Kaufman, J. (1999) · PubMed · Cited by 281
Opioid Analgesics and Rates of Fatal Drug Poisoning in the United States
PAULOZZI, L., & RYAN, G. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.08.017 · Cited by 280 · cited 2×
“-Endorphin Leu-enkephalin 0 Met-enkephalin 0 Dynorphin A (1-17) 0 Endomorphin-1 0 0 Endomorphin-2 0 0 Morphine 0 Heroin 0 Fentanyl 0 0 Sufentanil 0 0 Methadone 0 0 DALA (FK 33-824) 0 DAMME 0 U50,488H 0 0 Nalorphine 0 Naloxone Naltrexone CTOP 0 0 Buprenorphine / (?) Pentazocin 0”
Neuroendrocrine regulation of prolactin release
BENJONATHAN, N., ARBOGAST, L., & HYDE, J. (1989) · Progress in Neurobiology · doi:10.1016/0301-0082(89)90008-7 · Cited by 278
Role of cholecystokinin and opioid peptides in control of food intake
Baile, C. A., McLaughlin, C. L., & Della-Fera, M. A. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.1.172 · Cited by 276 · cited 2×
“sponses (30, 31), water and food intake (32), and regula-”
Adolescents' Motivations to Abuse Prescription Medications
Boyd, C. J., McCabe, S. E., Cranford, J. A., & Young, A. (2006) · Pediatrics · doi:10.1542/peds.2006-1644 · Cited by 271
Daniell, H. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.08.005 · Cited by 263 · cited 5×
“Daniell HW, Lentz R, Mazer NA 2006 Open-label pilot Downloaded from https://academic.oup.com/edrv/article-abstract/31/1/98/2354848 by guest on 28 July 2018 study of testosterone patch therapy in men with opioidinduced androgen deficiency.”
InfluentialMolecular pharmacology of the opioid receptors
Satoh, M., & Minami, M. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02011-x · Cited by 257
The Endomorphin System and Its Evolving Neurophysiological Role
Fichna, J., Janecka, A., Costentin, J., & Do Rego, J.-C. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.1.3 · Cited by 250
Fracture risk associated with the use of morphine and opiates
VESTERGAARD, P., REJNMARK, L., & MOSEKILDE, L. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01667.x · Cited by 244
Bliesener, N., Albrecht, S., Schwager, A., Weckbecker, K., Lichtermann, D., & Klingmüller, D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0929 · Cited by 236
National Drug Control Policy and Prescription Drug Abuse: Facts and Fallacies
Manchikanti, L. (2007) · Pain Physician · doi:10.36076/ppj.2007/10/399 · Cited by 219
Induction of Copulatory Behavior in Sexually Inactive Rats by Naloxone
Gessa, G. L., Paglietti, E., & Quarantotti, B. P. (1979) · Science · doi:10.1126/science.432642 · Cited by 215 · cited 2×
“active female rats (246), and facilitated sexual receptivity”
Lutfy, K., Eitan, S., Bryant, C. D., Yang, Y. C., Saliminejad, N., Walwyn, W., Kieffer, B. L., Takeshima, H., Carroll, F. I., Maidment, N. T., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10331.2003 · Cited by 211
Self-citationDifferential effects of morphine on food and water intake in food deprived and freely-feeding rats
Sanger, D. J., & McCarthy, P. S. (1980) · Psychopharmacology · doi:10.1007/bf00433813 · Cited by 204
Veldhuis, J. D., Rogol, A. D., Samojlik, E., & Ertel, N. H. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111417 · Cited by 197 · cited 2×
“Naloxone and other opioid antagonists increased basal and stimulated LH levels (229, 231).”
The suppressant effects of naloxone on food and water intake in the rat
Frenk, H., & Rogers, G. H. (1979) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(79)92855-3 · Cited by 194
Bone mineral density in subjects using central nervous system-active medications
Kinjo, M., Setoguchi, S., Schneeweiss, S., & Solomon, D. H. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.033 · Cited by 191
Smiley, J. F., & Goldman, P. S. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960408)367:3<431::aid-cne8>3.0.co;2-6 · Cited by 187
Androgen Deprivation Therapy in Prostate Cancer and Metabolic Risk for Atherosclerosis
Shahani, S., Braga-Basaria, M., & Basaria, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2595 · Cited by 185 · cited 2×
“In males, chronic hypogonadism, either spontaneous or induced by GnRH agonists, is associated with increased insulin resistance and risk for diabetes mellitus, but not frank hyperglycemia (398), and testosterone replacement may improve insulin resistance (399).”
Differential Effects of Opiate Peptides and Alkaloids on Anterior Pituitary Hormone Secretion
Delitala, G., Grossman, A., & Besser, M. (1983) · Neuroendocrinology · doi:10.1159/000123558 · Cited by 184 · cited 1×
“Intravenous morphine and morphine analogs such as methadone, DAMME, pentazocine, and nalorphine decreased LH levels in healthy men (149, 151).”
Chrousos, G. P. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30191-9 · Cited by 182
Medication Use Characteristics in the Elderly: The Iowa 65 + Rural Health Study
Helling, D. K., Lemke, J. H., Semla, T. P., Wallace, R. B., Lipson, D. P., & Cornoni‐Huntley, J. (1987) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1987.tb01312.x · Cited by 179
Opioids and consummatory behavior
Levine, A. S., Morley, J. E., Gosnell, B. A., Billington, C. J., & Bartness, T. J. (1985) · Brain Research Bulletin · doi:10.1016/0361-9230(85)90116-9 · Cited by 179
The Endogenous Opioid System and Clinical Pain Management
Holden, J. E., Jeong, Y., & Forrest, J. M. (2005) · AACN Clinical Issues: Advanced Practice in Acute and Critical Care · doi:10.1097/00044067-200507000-00003 · Cited by 174 · cited 3×
“Opioids can also facilitate the function of the descending pain inhibitory systems by inhibiting the activity of -aminobutyric acid-ergic interneurons (44, 45).”
Buckingham, J. C., & Cooper, T. A. (1984) · Neuroendocrinology · doi:10.1159/000123927 · Cited by 173 · cited 2×
“stimulate the release of stress hormones (160, 163).”
The Endocrinology of the Opioids
Millan, M. J., & Herz, A. (1985) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60072-0 · Cited by 169
Gonadal function in male heroin and methadone addicts
RAGNI, G., de LAURETIS, L., BESTETTI, O., SGHEDONI, D., & ARO, V. G. A. (1988) · International Journal of Andrology · doi:10.1111/j.1365-2605.1988.tb00984.x · Cited by 169
Erectile Dysfunction in Men Receiving Methadone and Buprenorphine Maintenance Treatment
Hallinan, R., Byrne, A., Agho, K., McMahon, C., Tynan, P., & Attia, J. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00702.x · Cited by 166
Effects of long-term therapy with naltrexone on body weight in obesity
Atkinson, R. L., Berke, L. K., Drake, C. R., Bibbs, M. L., Williams, F. L., & Kaiser, D. L. (1985) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1985.197 · Cited by 163 · cited 1×
“Interestingly, obese women treated with naloxone showed more significant weight loss than obese men (383), which may be linked to a sex-related difference in opioid effects.”
THE ANTIDIURETIC ACTION OF MORPHINE, AND ITS MECHANISM
DE BODO, R. C. (1944) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)08575-1 · Cited by 157
Yen, S. S. C., QUIGLEY, M. E., Reid, R. L., ROPERT, J. F., & Cetel, N. S. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(85)80162-9 · Cited by 151
Endogenous opioid peptides and hypothalamic neuroendocrine neurones
Bicknell, R. J. (1985) · Journal of Endocrinology · doi:10.1677/joe.0.1070437 · Cited by 147
Opioid reward mechanisms: a key role in drug abuse?
Herz, A. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-3-252 · Cited by 146 · cited 1×
“In addition, morphine binds, albeit with lower affinity, to the - and -opioid receptors (52).”
Hypogonadism in patients treated with intrathecal morphine
Finch, P. M., Roberts, L. J., Price, L., Hadlow, N. C., & Pullan, P. T. (2000) · The Clinical Journal of Pain · doi:10.1097/00002508-200009000-00011 · Cited by 144 · cited 1×
“In chronic pain patients receiving intrathecal morphine, hypogonadism was found in men and in both pre- and postmenopausal women (294).”
Altered sexual function and decreased testosterone in patients receiving intraspinal opioids
Pake, J. A., Penn, R. D., & Ryan, W. G. (1994) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)90166-x · Cited by 140
Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency
Daniell, H. W., Lentz, R., & Mazer, N. A. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.10.009 · Cited by 135
Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa*
Marrazzi, M. A., Bacon, J. P., Kinzie, J., & Luby, E. D. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199510030-00005 · Cited by 132 · cited 1×
“Concordantly, naltrexone administration reduced binge purging tendencies in bulimic and anorexic patients (385).”
Enkephalins and endorphins as modifiers of the immune system: present and future.
Wybran, J. (1985) · PubMed · Cited by 131
The μ-opioid receptor is necessary for [d-Pen2,d-Pen5]enkephalin-induced analgesia
Sora, I., Funada, M., & Uhl, G. R. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)10016-4 · Cited by 129
Frankenhaeuser, M. (1981) · International Journal of Health Services · doi:10.2190/l7lk-4t4d-klvv-a9p6 · Cited by 127
Kalyuzhny, A. E., Arvidsson, U., Wu, W., & Wessendorf, M. W. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06490.1996 · Cited by 126
Effects of morphine and β-endorphin on basal and elevated plasma levels of α-MSH and vasopressin
Greidanus, T. B. V. W., Thody, T. J., Verspaget, H. W., de Rotte, G. A., Goedemans, H. J., Croiset, G., & van Ree, J. M. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90153-x · Cited by 126
Roth, K. A., Weber, E., Barchas, J. D., Chang, D., & Chang, J.-K. (1983) · Science · doi:10.1126/science.6129700 · Cited by 124 · cited 1×
“In addition, dynorphin-like peptides have been found to colocalize with CRH and may be cosecreted with CRH in the hypophyseal portal circulation to modulate ACTH release (63).”
Arnauld, E., Cirino, M., Layton, B. S., & Renaud, L. P. (1983) · Neuroendocrinology · doi:10.1159/000123455 · Cited by 123
SENSITIVITY TO ENKEPHALIN AS A CAUSE OF NON-INSULIN DEPENDENT DIABETES
Leslie, R. D. G., Pyke, D. A., & STUBBS, W. A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92887-3 · Cited by 123
Opiate receptors in rat pituitary are confined to the neural lobe and are exclusively kappa
Herkenham, M. A., Rice, K. C., Jacobson, A. E., & Rothman, R. B. (1986) · Brain Research · doi:10.1016/0006-8993(86)91346-6 · Cited by 121
The Disappearance of Opioidergic Regulation of Gonadotropin Secretion in Postmenopausal Women*
REID, R. L., QUIGLEY, M. E., & YEN, S. S. C. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-6-1107 · Cited by 119
Asadikaram, G., Reisi, M., Kaseb, A. A., Khaksari, M., Mohammadi, A., & Mahmoodi, M. (2004) · Addiction Biology · doi:10.1080/13556210410001674095 · Cited by 119
Prevalence of Abuse and Dependency in Chronic Pain Patients
Hoffmann, N. G., Olofsson, O., Salen, B., & Wickstrom, L. (1995) · International Journal of the Addictions · doi:10.3109/10826089509055820 · Cited by 119 · cited 2×
“-Endorphin Leu-enkephalin 0 Met-enkephalin 0 Dynorphin A (1-17) 0 Endomorphin-1 0 0 Endomorphin-2 0 0 Morphine 0 Heroin 0 Fentanyl 0 0 Sufentanil 0 0 Methadone 0 0 DALA (FK 33-824) 0 DAMME 0 U50,488H 0 0 Nalorphine 0 Naloxone Naltrexone CTOP 0 0 Buprenorphine / (?) Pentazocin 0”
Feeding induced by opiates injected into the paraventricular hypothalamus.
Mclean, S., & Hoebel, B. (1983) · Peptides · doi:10.1016/0196-9781(83)90134-1 · Cited by 118
Chronic fentanyl application induces adrenocortical insufficiency
OLTMANNS, K. M., FEHM, H. L., & PETERS, A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01483.x · Cited by 117
Bhanot, R., & Wilkinson, M. (1983) · Endocrinology · doi:10.1210/endo-113-2-596 · Cited by 117
GABRIEL, S. M., SIMPKINS, J. W., & KALRA, S. P. (1983) · Endocrinology · doi:10.1210/endo-113-5-1806 · Cited by 116 · cited 1×
“Tonic inhibition of LH levels by central opioid neurons occurred at all stages of the female rat cycle (219), with the luteal phase being the main phase affected.”
THE NEUROENDOCRINOLOGY OF OPIOID PEPTIDES
GROSSMAN, A., & REES, L. H. (1983) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071796 · Cited by 116
Morphine selectively influences macronutrient intake in the rat
Marks-Kaufman, R., & Kanarek, R. B. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90048-9 · Cited by 116
Kalivas, P. W., & Abhold, R. H. (1987) · Brain Research · doi:10.1016/0006-8993(87)90015-1 · Cited by 115 · cited 1×
“Endogenous opioid peptides, particularly enkephalins, are released at numerous central nervous system (CNS) structures that play a critical role in pain modulation (48, 49).”
Vugt, D. A. V., LAM, N. Y., & Ferin, M. (1984) · Endocrinology · doi:10.1210/endo-115-3-1095 · Cited by 114
Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women
Fraser, L.-A., Morrison, D., Morley-Forster, P., Paul, T., Tokmakejian, S., Larry Nicholson, R., Bureau, Y., Friedman, T., & Uum, S. H. M. V. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1076715 · Cited by 112
Self-citationEffects of prenatal exposure to morphine on the development of sexual behavior in rats
Vathy, I., Etgen, A. M., & Barfield, R. J. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90382-x · Cited by 106
Addressing the intersecting problems of opioid misuse and chronic pain treatment.
Denisco, R. A., Chandler, R. K., & Compton, W. M. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0013636 · Cited by 105 · cited 1×
“In summary, the greatest factor associated with increasing prevalence of prescription opioid misuse appears to be the increased willingness of physicians to prescribe these drugs (19).”
Andropause: is androgen replacement therapy indicated for the aging male?
Hijazi, R. A., & Cunningham, G. R. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104518 · Cited by 105 · cited 1×
“Male hypogonadism can lead to symptoms of decreased sexual libido, erectile dysfunction, and osteoporosis (293).”
Brain opiates and neuroendocrine function
Grossman, A. B. (1983) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(83)80062-0 · Cited by 104
RELEASE OF VASOPRESSIN BY ENKEPHALIN
BISSET, G. W., CHOWDREY, H. S., & FELDBERG, W. (1978) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1978.tb08472.x · Cited by 102 · cited 1×
“tributed to the antidiuretic response in rats (305, 306).”
RITTMASTER, R. S., CUTLER, G. B., SOBEL, D. O., GOLDSTEIN, D. S., KOPPELMAN, M. C. S., LORIAUX, D. L., & CHROUSOS, G. P. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-5-891 · Cited by 102 · cited 15×
“Subsequently, CRH binds to its receptor in the anterior pituitary that leads to the synthesis of POMC, a large precursor molecule that is cleaved into several smaller functional peptides, such as ACTH and -endorphin (67).”
InfluentialEndogenous opiates and behavior: 2004
Bodnar, R. J., & Klein, G. E. (2005) · Peptides · doi:10.1016/j.peptides.2005.06.010 · Cited by 101
Opiate receptor localization in rat cerebral cortex
Lewis, M. E., Pert, A., Pert, C. B., & Herkenham, M. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902160310 · Cited by 100
Burton, H. (1984) · Brain Research · doi:10.1016/0006-8993(84)90606-1 · Cited by 99
The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
Porreca, F., & Burks, T. F. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21992-9 · Cited by 98 · cited 1×
“tion of gastrointestinal (28, 33, 34), cardiovascular (35–”
Counteraction of Gonadal Steroid Inhibition of Luteinizing Hormone Release by Naloxone
Van Vugt, D. A., Sylvester, P. W., Aylsworth, C. F., & Meites, J. (1982) · Neuroendocrinology · doi:10.1159/000123312 · Cited by 97
Lightman, S., Iversen, L., & Forsling, M. (1982) · The Journal of Neuroscience · doi:10.1523/jneurosci.02-01-00078.1982 · Cited by 96 · cited 1×
“However, more recently, several studies using a variety of opioids including morphine (319), -endorphin (304, 319), leu-enkephalin analogs (320), and the met-enkephalin analogs, DAMME (321–323) and metkephamid acetate (324, 325), all indicate that opioids act directly to suppress AVP secretion.”
The ionic mechanisms underlying opioid actions
McFadzean, I. (1988) · Neuropeptides · doi:10.1016/0143-4179(88)90072-8 · Cited by 95 · cited 1×
“Opioids can also facilitate the function of the descending pain inhibitory systems by inhibiting the activity of -aminobutyric acid-ergic interneurons (44, 45).”
ELLINGBOE, J., VELDHUIS, J. D., MENDELSON, J. H., KUEHNLE, J. C., MELLO, N. K., & HOLBROOK, P. G. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-4-854 · Cited by 95
Allolio, B., Schulte, H. M., Deuβ, U., Kallabis, D., Hamel, E., & Winkelmann, W. (1987) · Acta Endocrinologica · doi:10.1530/acta.0.1140509 · Cited by 94 · cited 1×
“In normal subjects, in contrast to the effect in rodents, a single dose of a slow-release oral morphine suppressed ACTH, -endorphin, and cortisol levels both at baseline and after CRH stimulation (180).”
Williams, F. G., Mullett, M. A., & Beitz, A. J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00554-4 · Cited by 94 · cited 1×
“Endogenous opioid peptides, particularly enkephalins, are released at numerous central nervous system (CNS) structures that play a critical role in pain modulation (48, 49).”
INDUCTION OF OVULATION BY THE CHRONIC ADMINISTRATION OF NALTREXONE IN HYPOTHALAMIC AMENORRHEA
WILDT, L., & LEYENDECKER, G. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1334 · Cited by 92
The inhibitory effect of opiates on gonadotrophin secretion is dependent upon gonadal steroids
Bhanot, R., & Wilkinson, M. (1984) · Journal of Endocrinology · doi:10.1677/joe.0.1020133 · Cited by 91 · cited 3×
“Bhanot and Wilkinson (221) showed that after gonadectomy, there was an acute reduction in the inhibitory effects of opioids on LH and FSH release, along with a reduced ability of naloxone to stimulate LH and FSH at all stages of development.”
InfluentialOpioids and sexual behavior in the male rat
Ågmo, A., & Paredes, R. G. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90135-9 · Cited by 91 · cited 1×
“In male rats, treatment with morphine inhibited sexual behavior with dose-dependent reductions in mounting, intromission, and ejaculation frequency (244).”
Effects of a Kappa-Opioid Agonist on Adrenocorticotropic and Diuretic Function in Man
Pfeiffer, A. F. H., Knepel, W., Braun, S. L., MEYER, H.-D., Lohmann, H., & Brantl, V. (1986) · Hormone and Metabolic Research · doi:10.1055/s-2007-1012453 · Cited by 89 · cited 1×
“The primary opioid receptor involved in the regulation of the HPA axis is most likely the -receptor (194, 195).”
A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin
Summy‐Long, J. Y., Miller, D. S., Rosella-Dampman, L. M., Hartman, R. D., & Emmert, S. E. (1984) · Brain Research · doi:10.1016/0006-8993(84)90605-x · Cited by 89
Inhibition of vasopressin release in man by an opiate peptide
GROSSMAN, A. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92542-8 · Cited by 88
Wakerley, J. B., Noble, R., & Clarke, G. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90081-7 · Cited by 87
Blank, M. S., & Roberts, D. L. (1982) · Neuroendocrinology · doi:10.1159/000123399 · Cited by 87
Opioids Are They Regulators of Feeding?a
Levine, A. S., & Billington, C. J. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb53244.x · Cited by 86
Naber, D., Pickar, D., Davis, G. C., Cohen, R. M., Jimerson, D. C., Elchisak, M. A., Defraites, E. G., Kalin, N. H., Risch, S. C., & Buchsbaum, M. S. (1981) · Psychopharmacology · doi:10.1007/bf00432677 · Cited by 85
Which Opioid Receptor Mechanism Modulates Feeding?
Morley, J. E., Levine, A. S., Gosnell, B. A., & Billington, C. J. (1984) · Appetite · doi:10.1016/s0195-6663(84)80051-3 · Cited by 82
Mainly μ-Opiate Receptors Are Involved in Luteinizing Hormone and Prolactin Secretion
PANERAI, A. E., PETRAGLIA, F., SACERDOTE, P., & GENAZZANI, A. R. (1985) · Endocrinology · doi:10.1210/endo-117-3-1096 · Cited by 80
Biosynthesis of the Morphine Alkaloids
KIRBY, G. W. (1967) · Science · doi:10.1126/science.155.3759.170 · Cited by 80
Morphine, Opioid Peptides, and Pancreatic Islet Function
Giugliano, D. (1984) · Diabetes Care · doi:10.2337/diacare.7.1.92 · Cited by 79 · cited 2×
“prevalence of glucose disorders in this population (396).”
STUDIES OF THE OPIATE CONTROL OF PROLACTIN, GH AND TSH
GROSSMAN, A., STUBBS, W. A., GAILLARD, R. C., DELITALA, G., REES, L. H., & BESSER, G. M. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00624.x · Cited by 79
Interruption of parturition in rats by morphine: a result of inhibition of oxytocin secretion
Russell, J. A., Gosden, R. G., Humphreys, E. M., Cutting, R., Fitzsimons, N., Johnston, V., Liddle, S., Scott, S., & Stirland, J. A. (1989) · Journal of Endocrinology · doi:10.1677/joe.0.1210521 · Cited by 79 · cited 1×
“to the mother during birth inhibited the levels of OT and impaired maternal behavior (339).”
Wiesner, J. B., Koenig, J. I., Krulich, L., & Moss, R. L. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90061-4 · Cited by 78
The Availability of Web Sites Offering to Sell Opioid Medications Without Prescriptions
Forman, R. F. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.7.1233 · Cited by 77 · cited 1×
“The Internet has also been a portal for sales and access to prescription opioids (18), although as stated above, the percentage as reported in surveys is probably low.”
The endogenous opioid system in neurological disorders of the basal ganglia
Sandyk, R. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90292-9 · Cited by 76 · cited 1×
“activity (26), seizure threshold (27–29), immune re-”
Opioids and neuropeptides: mechanisms in circulatory shock.
Bernton, E. W., Long, J., & Holaday, J. W. (1985) · PubMed · Cited by 76
Role of β‐Endorphin in Behavioral Regulationa
Izquierdo, I., & Netto, C. A. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb37587.x · Cited by 75
Localization of the antinociceptive action of morphine in primate brain
Pert, A., & Yaksh, T. L. (1975) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(75)90092-1 · Cited by 75 · cited 1×
“In addition, opioids suppress pain perception at the somatosensory cortex and alter the affective component of pain via an action at the level of the limbic structures (46).”
Long-term morphine treatment decreases endorphin levels in rat brain and pituitary
Przewłocki, R., Ho¨llt, V., Duka, T., Kleber, G., Gramsch, C., Haarmann, I., & Herz, A. (1979) · Brain Research · doi:10.1016/0006-8993(79)90862-x · Cited by 74
Facilitation by opiate antagonists of sexual performance in the male rat
Myers, B., & Baum, M. J. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90242-9 · Cited by 74 · cited 1×
“In sexually inactive male rats, naloxone was able to induce copulatory behavior (246), and it reduced the number of intromissions before ejaculation and before the time of latency (247, 248).”
Fabbri, A., Jannini, E. A., Gnessi, L., Moretti, C., Ulisse, S., Franzese, A., Lazzari, R., FRAIOLI, F., Frajese, G., & Isidori, A. M. (1989) · Psychoneuroendocrinology · doi:10.1016/0306-4530(89)90059-0 · Cited by 73
BERGLUND, L. A., DERENDORF, H., & SIMPKIN, J. W. (1988) · Endocrinology · doi:10.1210/endo-122-6-2718 · Cited by 73
Different Opioid Mechanisms Are Involved in the Modulation of ACTH and Gonadotrophin Release in Man
Grossman, A., Moult, P. J. A., Cunnah, D., & Besser, M. (2008) · Neuroendocrinology · doi:10.1159/000124463 · Cited by 73 · cited 1×
“The primary opioid receptor involved in the regulation of the HPA axis is most likely the -receptor (194, 195).”
Courteix, C., Bourget, P., Caussade, F., Bardin, M., Coudoré, F., Fialip, J., & Eschalier, A. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37362-8 · Cited by 73 · cited 1×
“The antinociceptive effects of morphine were reduced in streptozocin-induced diabetic rats, which is explained not by decreasing numbers of opioid receptors or receptor affinities to morphine but by alterations in the pharmacokinetics of morphine (380).”
Functional μ Opioid Receptors Are Reduced in the Spinal Cord Dorsal Horn of Diabetic Rats
Chen, S.-R., Sweigart, K. L., Lakoski, J. M., & Pan, H. (2002) · Anesthesiology · doi:10.1097/00000542-200212000-00037 · Cited by 72
Selective activation of opioid receptors differentially affects lordosis behavior in female rats
Pfaus, J. G., & Gorzalka, B. B. (1987) · Peptides · doi:10.1016/0196-9781(87)90106-9 · Cited by 72 · cited 1×
“-receptors and/or -receptors facilitated lordosis (256).”
Importance of NPY Y1 receptor-mediated pathways: assessment using NPY Y1 receptor knockouts
Pedrazzini, T. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.007 · Cited by 70 · cited 1×
“Acutely injected heroin increased immunoreactivity of neuropeptide Y in the thalamic paraventricular nucleus and nucleus of stria terminalis (366, 367), areas known to stimulate food intake and thus lead to an increased likelihood of obesity.”
Naloxone-Induced Luteinizing Hormone Secretion in Normal, Precocious, and Delayed Puberty*
Petraglia, F., Bernasconi, S., Iughetti, L., Loche, S., ROMANINI, F., Facchinetti, F., Marcellini, C., & Genazzani, A. R. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-5-1112 · Cited by 68 · cited 2×
“In a similar study, naloxone administration in both early and late pubertal boys resulted in stimulation of LH secretion in late pubertal boys, whereas no effect was found in early pubertal boys (240).”
Pittius, C. W., Kley, N., Loeffler, J., & Höllt, V. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03769.x · Cited by 67 · cited 1×
“In contrast, nonhumans have little or no met-enkephalin in the anterior lobe of the pituitary (155).”
Petraglia, F., Porro, C., Facchinetti, F., Cicoli, C., Bertellini, E., Volpe, A., Barbieri, G. C., & Genazzani, A. R. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90209-2 · Cited by 66
Yeap, B. B., Almeida, O. P., Hyde, Z., Chubb, S. A. P., Hankey, G. J., Jamrozik, K., & Flicker, L. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03055.x · Cited by 65
Band, L. C., & Hull, E. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90494-v · Cited by 65 · cited 1×
“uated by systemic naloxone administration (252, 253).”
Opioids and sexual behavior of male rats: Involvement of the medial preoptic area.
van Furth, W. R., van Emst, M. G., & van Ree, J. M. (1995) · Behavioral Neuroscience · doi:10.1037//0735-7044.109.1.123 · Cited by 64
CASE DEFINITIONS FOR PAEDIATRIC AIDS APPLIED TO AFRICAN CHILDREN SEEN IN BELGIUM
Jonckheer, T., Levy, J., Ninane, J., Alimenti, A., François, A., & Hemeldonck, A. V. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91524-3 · Cited by 63
Neuroendocrine-specific Expression of the Human Prohormone Convertase 1 Gene
Jansen, E., Ayoubi, T., Meulemans, S. M. P., & de Ven, W. J. M. V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15391 · Cited by 63
Cacicedo, L., & Franco, F. S. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90055-x · Cited by 63 · cited 1×
“Studies on the pituitary as a primary site of action for -endorphin are conflicting because one study (208) found a direct effect of -endorphin on LH release, whereas another (206) did not find such a direct effect.”
Houshyar, H., Cooper, Z. D., & Woods, J. H. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00713.x · Cited by 62
Heroin Addiction: Neurobiology, Pharmacology, and Policy
Goldstein, A. (1991) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1991.10472231 · Cited by 62 · cited 1×
“This -receptor agonist is highly addictive (55).”
A Clinical Guide to the Diagnosis and Treatment of Heroin-Related Sexual Dysfunction
Smith, D. E., Moser, C., Wesson, D. R., Apter, M., Buxton, M. E., Davison, J. V., Orgel, M., & Buffum, J. (1982) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1982.10471916 · Cited by 62 · cited 1×
“Heroin users appear to have decreased sexual desire and performance (268), but in general, the effects of chronic opioid treatment on libido and/or fertility in women have not been documented in well-con-”
Impaired circadian rhythmicity of β-lipotrophin, β-endorphin and ACTH in heroin addicts
Facchinetti, F., Grasso, A., Petraglia, F., Parrini, D., Volpe, A., & Genazzani, A. R. (1984) · Acta Endocrinologica · doi:10.1530/acta.0.1050149 · Cited by 61
The cardiovascular actions of morphine and the endogenous opioid peptides
Johnson, M. W., Mitch, W. E., & Wilcox, C. S. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(85)90004-0 · Cited by 61
Sirinathsinghji, D. J. S., Motta, M., & Martini, L. (1985) · Journal of Endocrinology · doi:10.1677/joe.0.1040299 · Cited by 60 · cited 2×
“By the same mechanism, naloxone administered to immature female rats advanced the age of onset of puberty (226).”
Spinal opiates affect sexual behaviour in rats
Wiesenfeld‐Hallin, Z., & Södersten, P. (1984) · Nature · doi:10.1038/309257a0 · Cited by 60
LACK OF ENDOGENOUS OPIOID INHIBITORY TONE ON LH SECRETION IN EARLY PUBERTY
FRAIOLI, F., Cappa, M., Fabbri, A., Gnessi, L., Moretti, C., Borrelli, P., & Isidori, A. M. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00086.x · Cited by 59
Rayner, V. C., Robinson, I. C., & Russell, J. A. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp016964 · Cited by 58 · cited 1×
“In normally hydrated rats, morphine caused a dose-dependent reduction in plasma OT levels in virgin but not lactating rats (337), and similar OT levels were found in morphine-treated and untreated lactating rats (338).”
Wehrenberg, W. B., Bloch, B., & Ling, N. (2008) · Neuroendocrinology · doi:10.1159/000124147 · Cited by 58
Gudehithlu, K. P., Tehwani, G. A., & Bhargava, H. N. (1991) · Brain Research · doi:10.1016/0006-8993(91)90836-k · Cited by 58
Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome
Ahmed, M. I., Duleba, A. J., El Shahat, O., Ibrahim, M. E., & Salem, A. (2008) · Human Reproduction · doi:10.1093/humrep/den273 · Cited by 58
The Availability of Web Sites Offering to Sell Opioid Medications Without Prescriptions
Forman, R. F., WOODY, G. E., McLellan, T., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.7.1233 · Cited by 58
Mauras, N., Veldhuis, J. D., & Rogol, A. D. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-6-1256 · Cited by 57 · cited 1×
“effect of naltrexone in sexually developed boys compared with prepubertal boys: in the developed boys in late puberty naltrexone increased, whereas in the sexually immatureboysnaltrexonedecreasedLHpulse frequencyand concentration (239).”
Schluger, J. H., Bart, G. B., Green, M., Ho, A., & Kreek, M. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300156 · Cited by 57 · cited 1×
“(189) found that methadone-maintained former heroin addicts displayed a significantly greater increase in plasma ACTH, but not cortisol levels after high-dose but not low-dose human CRH, suggesting that the HPA axis is not completely recovered in methadone maintenance.”
Ježová, D., Vigas, M., & Jur̀čovičová, J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90407-6 · Cited by 57 · cited 1×
“Acute administration of morphine led to a robust increase in ACTH and CS levels (159).”
Yilmaz, B., Konar, V., Kutlu, S., Sandal, S., Canpolat, S., Gezen, M. R., & Kelestimur, H. (1999) · Archives of Andrology · doi:10.1080/014850199262481 · Cited by 56 · cited 2×
“As a result of a morphine-induced decrease in LH levels, testosterone and estradiol levels are also decreased (211).”
HARTMAN, R. D., ROSELLA-DAMPMAN, L. M., EMMERT, S. E., & SUMMY-LONG, J. Y. (1986) · Endocrinology · doi:10.1210/endo-119-1-1 · Cited by 55 · cited 1×
“In general, acute administration of opioids inhibits OT release (295, 301).”
Rushen, J., Schwarze, N., Ladewig, J., & Foxcroft, G. R. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90270-p · Cited by 54 · cited 1×
“Although one paper in pigs reported that administration of naloxone enhanced the stress-induced increase in PRL secretion (81), this response was mild and was not confirmed statistically.”
Kapas, S., Purbrick, A., & Hinson, J. P. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1440503 · Cited by 53
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea
Genazzani, A. D., Petraglia, F., Gastaldi, M., Volpogni, C., Gamba, O., & Genazzani, A. R. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57908-4 · Cited by 52
Endogenous opioid peptides and the control of the menstrual cycle
Ferin, M., & Wiele, R. L. V. (1984) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(84)90059-5 · Cited by 52 · cited 1×
“Exogenous opioids and endogenous opioid peptides caused a significant decrease in LH pulse frequency (224), whereas naloxone promoted an increase in the LH surge compared with saline controls (225).”
Mechanism of diuretic action of spiradoline (U‐62066E)‐a kappa opioid receptor agonist in the human.
Rimoy, G., Bhaskar, N., Wright, D., & Rubin, P. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb03960.x · Cited by 51
Pumford, K. M., Leng, G., & Russell, J. A. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018717 · Cited by 51
DE SOUZA, E. B., & VAN LOON, G. R. (1982) · Endocrinology · doi:10.1210/endo-111-5-1483 · Cited by 51
Li, S., & Pelletier, G. (1992) · Endocrinology · doi:10.1210/endo.131.1.1612019 · Cited by 51
Effect of methadone addiction on glucose metabolism in rats
Sadava, D., Alonso, D., Hong, H., & Pettit-Barrett, D. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00165-6 · Cited by 50
Naltrexone for the treatment of obesity: review and update
Lee, M. W., & Fujioka, K. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903048959 · Cited by 49
Orstead, M., & Spies, H. G. (2008) · Neuroendocrinology · doi:10.1159/000124791 · Cited by 49
Opioid modulation of gonadotropin and prolactin secretion in domestic farm animals
Barb, C. R., Kraeling, R. R., & Rampacek, G. B. (1991) · Domestic Animal Endocrinology · doi:10.1016/0739-7240(91)90036-j · Cited by 49
Testosterone Effects on Cognition in Health and Disease
Cherrier, M. M. (2008) · Frontiers of Hormone Research · doi:10.1159/000176051 · Cited by 48 · cited 1×
“ther studies may need to confirm this association and the potential benefit of testosterone therapy (290), it is currently unknown whether opioid-induced hypogonadism is associated with cognitive decline and other signs of hypogonadism.”
Olson, G. A., Olson, R. D., & Kastin, A. J. (1985) · Peptides · doi:10.1016/0196-9781(85)90181-0 · Cited by 48
Partial Characterization of a Neurotransmitter Pathway Regulating the in vivo Release of Prolactin
Flores, C. M., Hulihan-Giblin, B. A., Hornby, P. J., Lumpkin, M. D., & Kellar, K. J. (1992) · Neuroendocrinology · doi:10.1159/000126176 · Cited by 47 · cited 2×
“Most importantly, this study (108) supported the findings of Bero and Kuhn (106) that inhibition of dopaminergic pathways plays an important role in the induction of PRL release by opioids.”
Cetel, N. S., QUIGLEY, M. E., & Yen, S. S. C. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-1-191 · Cited by 47
Behaviourally-specific hyperdipsia in the non-deprived rat following acute morphine treatment
Cooper, S. J. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90179-9 · Cited by 46
Chronic morphine treatment inhibits oxytocin synthesis in rats
You, Z.-D., Li, J.-H., Song, C.-Y., Wang, C.-H., & Lu, C.-L. (2000) · Neuroreport · doi:10.1097/00001756-200009280-00015 · Cited by 45 · cited 1×
“In the supraoptic nucleus and nucleus accumbens of rats treated with morphine by ip injection for 7 d, decreased OT content and mRNA expression were seen by RIA and in situ hybridization, respectively (340).”
Allolio, B., Winkelmann, W., Hipp, F. X., KAULEN, D., & Mies, R. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-1-1 · Cited by 45
HARTMAN, R. D., ROSELLA-DAMPMAN, L. M., & SUMMY-LONG, J. Y. (1987) · Endocrinology · doi:10.1210/endo-121-2-536 · Cited by 44 · cited 2×
“(336) proposed that opioid peptides inhibit OT so that the pituitary can store and conserve OT needed for lactation.”
Stocche, R. (2001) · Regional Anesthesia and Pain Medicine · doi:10.1053/rapm.2001.27851 · Cited by 44 · cited 1×
“Other opioid analgesics, such as fentanyl or sufentanil, did not suppress OT levels before labor, but suppressed OT levels during the onset of labor (348, 349).”
Katakami, H., Kato, Y., Matsushita, N., Hiroto, S., Shimatsu, A., & Imura, H. (2008) · Neuroendocrinology · doi:10.1159/000123216 · Cited by 44
Effects of heroin on thyroid function, cortisol and testosterone level in addicts.
Rasheed, A., & Tareen, I. A. (1995) · PubMed · Cited by 44
Opiate antagonist treatment of ovarian failure
Wildt, L., Sir-Petermann, T., Leyendecker, G., Waibel-Treber, S., & Rabenbauer, B. (1993) · Human Reproduction · doi:10.1093/humrep/8.suppl_2.168 · Cited by 43
Chronic Morphine and Testosterone Treatment
Clark, J. T., Gabriel, S. M., Simpkins, J. W., Kalra, S. P., & Kalra, P. S. (1988) · Neuroendocrinology · doi:10.1159/000124996 · Cited by 43 · cited 1×
“Reports from other laboratories suggested that this reduction in sexual behavior was due to failure of sexual arousal, rather than a primary erectile inability (245).”
Opiate regulation of angiotensin-induced drinking and vasopressin release.
Summy‐Long, J. Y., KEIL, L. C., Deen, K., & Severs, W. B. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32583-8 · Cited by 43 · cited 2×
“AVP release (304), and another report found that dynor-”
Research works printed but not linked: 2
- 2009, International Narcotics Control Board 2007, March, press release no. 4: Abuse of prescription drugs to surpass illicit drug abuse, Drug Watch International, 12, 14
- Mansour, 1987, Autoradiographic differentiation of μ, δ, and κ opioid receptors in the rat forebrain and midbrain., J Neurosci, 7, 2445
Cited by
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122957 · Cited by 1,388
Clinical Management of Congenital Hypogonadotropic Hypogonadism
Young, J., Xu, C., Papadakis, G. E., Acierno, J. S., Maione, L., Hietamäki, J., Raivio, T., & Pitteloud, N. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00116 · Cited by 396
Mechanisms of Penile Erection and Basis for Pharmacological Treatment of Erectile Dysfunction
Andersson, K.-E. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004515 · Cited by 392
“…injection of opioids can lead to decreased libido and ED (Parr, 1976; Crowley and Simpson, 1978; Mirin et al., 1980; Abs et al., 2000; Hallinan et al., 2008), possibly because of hypogonadotropic hypogonadism (Mirin et al., 1980; Abs et al., 2000; Hallinan et al., 2008; Vuong et al., 2010).”
BackgroundJanssen, P., Vanden Berghe, P., Verschueren, S., Lehmann, A., Depoortere, I., & Tack, J. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04609.x · Cited by 348
“whether normal weight, low weight (anorexia patients) or obese volunteers ⁄ patients are selected.(132) We recently”
BackgroundBasaria, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61126-5 · Cited by 328
Metadata
- Authors
- Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C.
- Affiliations
- Charles R. Drew University of Medicine and Science (US)
- Department of Medicine (S.H.M.V.U.), University of Western Ontario, London, Ontario, Canada N6A 4V2;
- Department of Psychology (L.E.O.), University of Texas at El Paso, El Paso, Texas 79968;
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2009-11-10
- Volume
- 31
- Issue
- 1
- Pages
- 98-132
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2852206
- OpenAlex
- W2121855288
- Semantic Scholar
- b1cd06bbab24029ae38ff691e325cd99457b8455
- Cited by
- 564
- References
- 418
- Citations by year
- 2026: 22 · 2025: 33 · 2024: 25 · 2023: 34 · 2022: 36 · 2021: 37 · 2020: 35 · 2019: 41 · 2018: 52 · 2017: 32 · 2016: 37 · 2015: 42 · 2014: 34 · 2013: 29 · 2012: 32
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u54rr014616-10)
- National Institute on Drug Abuse (R01DA014659, R01 DA14659, R01 DA16682, R01DA016682, R01DA021274, R24DA017298, R25DA033613)
- National Center for Research Resources (U54-RR14616, G12RR003026, U54-RR0 14616, G21 RR03026)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD41748, U54HD041748)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- opioids, opioid analgesics, endocrine effects, growth hormone, prolactin, luteinizing hormone, testosterone, estradiol, oxytocin, thyroid-stimulating hormone, vasopressin, ACTH, opioid receptors, hypogonadism, dietary intake, hyperglycemia, insulin secretion, chronic pain, opioid abuse
- MeSH terms
- Analgesics, Opioid, Animals, Endocrine System Diseases, Endocrine System, Female, Humans, Hypogonadism, Male, Opioid-Related Disorders, Opiate Alkaloids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.